87 related articles for article (PubMed ID: 17955044)
21. Tyrosine kinase inhibitors and the thyroid as both an unintended and an intended target.
Vetter ML; Kaul S; Iqbal N
Endocr Pract; 2008; 14(5):618-24. PubMed ID: 18753108
[TBL] [Abstract][Full Text] [Related]
22. Tyrosine kinase inhibitors and acute pancreatitis.
Pezzilli R; Corinaldesi R; Morselli-Labate AM
JOP; 2010 May; 11(3):291-3. PubMed ID: 20442535
[No Abstract] [Full Text] [Related]
23. Eccrine squamous syringometaplasia associated with sunitinib therapy.
Sheen YS; Huang CL; Chu CY
J Eur Acad Dermatol Venereol; 2007 Sep; 21(8):1136-7. PubMed ID: 17714156
[No Abstract] [Full Text] [Related]
24. A novel tyrosine-kinase selective inhibitor, sunitinib, induces transient hypothyroidism by blocking iodine uptake.
Mannavola D; Coco P; Vannucchi G; Bertuelli R; Carletto M; Casali PG; Beck-Peccoz P; Fugazzola L
J Clin Endocrinol Metab; 2007 Sep; 92(9):3531-4. PubMed ID: 17595247
[TBL] [Abstract][Full Text] [Related]
25. [Gottron-like papules induced by sunitinib].
Martorell-Calatayud A; Sanmartín O; Traves-Zapata V; Guillén C
Actas Dermosifiliogr; 2011 Jun; 102(5):385-7. PubMed ID: 21481331
[No Abstract] [Full Text] [Related]
26. Case of sunitinib-induced Stevens-Johnson syndrome.
Lee JH; Lee JH; Lee JH; Kim SY; Kim GM
J Dermatol; 2013 Sep; 40(9):753-4. PubMed ID: 23855706
[No Abstract] [Full Text] [Related]
27. Scrotal cutaneous side effects of sunitinib.
Billemont B; Barete S; Rixe O
N Engl J Med; 2008 Aug; 359(9):975-6; discussion 976. PubMed ID: 18753659
[No Abstract] [Full Text] [Related]
28. Sunitinib-induced scrotal cutaneous side-effect.
Chou CY; Wang KH; Lin YH; Lin YT; Tsai HH
J Dermatol; 2013 Jan; 40(1):67-8. PubMed ID: 23078345
[No Abstract] [Full Text] [Related]
29. Acute hyperammonemic encephalopathy in a non-cirrhotic patient with hepatocellular carcinoma reversed by arginine therapy.
Shinde SS; Sharma P; Davis MP
J Pain Symptom Manage; 2014 Apr; 47(4):e5-7. PubMed ID: 24731681
[No Abstract] [Full Text] [Related]
30. Images in clinical medicine. Sunitinib-associated hair depigmentation.
Brzezniak C; Szabo E
N Engl J Med; 2014 Apr; 370(17):e27. PubMed ID: 24758639
[No Abstract] [Full Text] [Related]
31. Macrocytosis due to treatment with sunitinib.
Billemont B; Izzedine H; Rixe O
N Engl J Med; 2007 Sep; 357(13):1351-2; author reply 1352. PubMed ID: 17898111
[No Abstract] [Full Text] [Related]
32. Macrocytosis and cobalamin deficiency in patients treated with sunitinib.
Gillessen S; Graf L; Korte W; Cerny T
N Engl J Med; 2007 May; 356(22):2330-1. PubMed ID: 17538098
[No Abstract] [Full Text] [Related]
33. Lung toxicity in a patient treated with sunitinib.
Boyle HJ; Chatté G; Rivoire M; Fléchon A
Eur Respir J; 2012 Nov; 40(5):1300-3. PubMed ID: 23115316
[No Abstract] [Full Text] [Related]
34. Severe hypothyroidism presenting as myxedema coma in the postoperative period in a patient taking sunitinib: case report and review of literature.
Lele AV; Clutter S; Price E; De Ruyter ML
J Clin Anesth; 2013 Feb; 25(1):47-51. PubMed ID: 23246982
[TBL] [Abstract][Full Text] [Related]
35. Cancer and deliberate hypothyroidism, anesthesia, and myxedema coma: the curse of oncologic outcomes based on hypothyroidism.
Hatch DM; Roy RC
J Clin Anesth; 2013 Feb; 25(1):1-3. PubMed ID: 23246983
[No Abstract] [Full Text] [Related]
36. Erosive nappy erythema following sunitinib intake.
Kharmoum S; Errihani H
Pan Afr Med J; 2013; 14():46. PubMed ID: 23560129
[No Abstract] [Full Text] [Related]
37. "Pseudocavitation" in thymic carcinoma during treatment with sunitinib.
Tiseo M; Rajan A; Thomas A; Giaccone G
J Thorac Oncol; 2013 Apr; 8(4):511-2. PubMed ID: 23486269
[No Abstract] [Full Text] [Related]
38. Neoadjuvant treatment of unresectable medullary thyroid cancer with sunitinib.
Cleary JM; Sadow PM; Randolph GW; Palmer EL; Lynch TP; Nikiforov YE; Wirth LJ
J Clin Oncol; 2010 Aug; 28(23):e390-2. PubMed ID: 20567012
[No Abstract] [Full Text] [Related]
39. Re: Thyroid dysfunction from antineoplastic agents.
Hercbergs AA; Garfield D; Ashur-Fabian O; Davis PJ
J Natl Cancer Inst; 2012 Mar; 104(5):422-3; author reply 423. PubMed ID: 22291212
[No Abstract] [Full Text] [Related]
40. Risks associated with sunitinib use and monitoring to improve patient outcomes.
Choi BS
Korean J Intern Med; 2014 Jan; 29(1):23-6. PubMed ID: 24574829
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
